How effective medications are depends on various factors, including the time of day when they are administered.
Novo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q1
Novo Nordisk reported DKr61bn ($8.7bn) in sales from its diabetes and obesity portfolio, accounting for 93.3% of the total sales in Q1 this year. Image